Loading...

United Health Products

OTCPK:UEEC
Snowflake Description

Worrying balance sheet with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
UEEC
OTCPK
$158M
Market Cap
  1. Home
  2. US
  3. Healthcare
Company description

United Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. The last earnings update was 11 days ago. More info.


Add to Portfolio Compare Print
UEEC Share Price and Events
7 Day Returns
-5.8%
OTCPK:UEEC
0.9%
US Medical Equipment
-1.4%
US Market
1 Year Returns
-3.8%
OTCPK:UEEC
10.9%
US Medical Equipment
1.6%
US Market
UEEC Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
United Health Products (UEEC) -5.8% -1.4% -7.7% -3.8% 768.3% 670.9%
US Medical Equipment 0.9% 1.6% -0.9% 10.9% 55.9% 90.4%
US Market -1.4% -3.9% 0.2% 1.6% 33.2% 38.2%
1 Year Return vs Industry and Market
  • UEEC underperformed the Medical Equipment industry which returned 10.9% over the past year.
  • UEEC underperformed the Market in United States of America which returned 1.6% over the past year.
Price Volatility
UEEC
Industry
5yr Volatility vs Market

UEEC Value

 Is United Health Products undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.

In this section, we usually try to help investors determine whether United Health Products is trading at an attractive price based on the cash flow it is expected to produce in the future. But as United Health Products has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis. You can see them here.

Show me the analysis anyway

INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for United Health Products. This is due to cash flow or dividend data being unavailable. The share price is $0.895.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for United Health Products's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are United Health Products's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
OTCPK:UEEC PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-03-31) in USD $-0.03
OTCPK:UEEC Share Price ** OTCPK (2019-05-24) in USD $0.9
United States of America Medical Equipment Industry PE Ratio Median Figure of 64 Publicly-Listed Medical Equipment Companies 39.05x
United States of America Market PE Ratio Median Figure of 3,084 Publicly-Listed Companies 17.44x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of United Health Products.

OTCPK:UEEC PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= OTCPK:UEEC Share Price ÷ EPS (both in USD)

= 0.9 ÷ -0.03

-30.61x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • United Health Products is loss making, we can't compare its value to the US Medical Equipment industry average.
  • United Health Products is loss making, we can't compare the value of its earnings to the United States of America market.
Price based on expected Growth
Does United Health Products's expected growth come at a high price?
Raw Data
OTCPK:UEEC PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -30.61x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
United States of America Medical Equipment Industry PEG Ratio Median Figure of 55 Publicly-Listed Medical Equipment Companies 2.12x
United States of America Market PEG Ratio Median Figure of 2,121 Publicly-Listed Companies 1.51x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for United Health Products, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on United Health Products's assets?
Raw Data
OTCPK:UEEC PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-03-31) in USD $0.00
OTCPK:UEEC Share Price * OTCPK (2019-05-24) in USD $0.9
United States of America Medical Equipment Industry PB Ratio Median Figure of 182 Publicly-Listed Medical Equipment Companies 4.42x
United States of America Market PB Ratio Median Figure of 5,207 Publicly-Listed Companies 1.8x
OTCPK:UEEC PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= OTCPK:UEEC Share Price ÷ Book Value per Share (both in USD)

= 0.9 ÷ 0.00

-289.18x

* Primary Listing of United Health Products.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • United Health Products has negative assets, we can't compare the value of its assets to the US Medical Equipment industry average.

Next steps:

  1. Take a look at our analysis of UEEC’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  2. Show me more potentially undervalued companies in the Medical Equipment industry
  3. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Value checks
We assess United Health Products's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Medical Equipment industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Medical Equipment industry average (and greater than 0)? (1 check)
  5. United Health Products has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

UEEC Future Performance

 How is United Health Products expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as United Health Products has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
21.5%
Expected Medical Equipment industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is United Health Products expected to grow at an attractive rate?
  • Unable to compare United Health Products's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare United Health Products's earnings growth to the United States of America market average as no estimate data is available.
  • Unable to compare United Health Products's revenue growth to the United States of America market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
OTCPK:UEEC Future Growth Rates Data Sources
Data Point Source Value (per year)
United States of America Medical Equipment Industry Earnings Growth Rate Market Cap Weighted Average 21.5%
United States of America Medical Equipment Industry Revenue Growth Rate Market Cap Weighted Average 8.1%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 13.7%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.3%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
OTCPK:UEEC Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
OTCPK:UEEC Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-03-31 0 -1 -5
2018-12-31 0 -1 -6
2018-09-30 0 -1 -6
2018-06-30 0 -1 -6
2018-03-31 0 -1 -5
2017-12-31 1 -1 -1
2017-09-30 0 0 0
2017-06-30 0 0 0
2017-03-31 0 0 0
2016-12-31 0 0 -1
2016-09-30 0 -1 -1
2016-06-30 0 -1 -1

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if United Health Products is high growth as no earnings estimate data is available.
  • Unable to determine if United Health Products is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
OTCPK:UEEC Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from United Health Products Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:UEEC Past Financials Data
Date (Data in USD Millions) EPS *
2019-03-31 -0.03
2018-12-31 -0.04
2018-09-30 -0.04
2018-06-30 -0.04
2018-03-31 -0.03
2017-12-31 -0.01
2017-09-30 0.00
2017-06-30 0.00
2017-03-31 0.00
2016-12-31 0.00
2016-09-30 -0.01
2016-06-30 -0.01

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if United Health Products will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Take a look at our analysis of UEEC’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  2. United Health Products's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Healthcare companies here
  3. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access United Health Products's filings and announcements here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess United Health Products's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
United Health Products has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

UEEC Past Performance

  How has United Health Products performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare United Health Products's growth in the last year to its industry (Medical Equipment).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • United Health Products does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare United Health Products's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare United Health Products's 1-year growth to the US Medical Equipment industry average as it is not currently profitable.
Earnings and Revenue History
United Health Products's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from United Health Products Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:UEEC Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-03-31 0.02 -5.00 4.83 0.10
2018-12-31 0.05 -6.01 2.25 0.08
2018-09-30 0.35 -6.03 2.54
2018-06-30 0.41 -5.78 2.32
2018-03-31 0.45 -4.98 1.51 0.02
2017-12-31 0.65 -0.93 1.28 0.02
2017-09-30 0.50 -0.39 0.73
2017-06-30 0.45 -0.42 0.72
2017-03-31 0.43 -0.37 0.66
2016-12-31 0.24 -0.54 0.64
2016-09-30 0.08 -0.82 0.85
2016-06-30 0.08 -1.05 1.07
2016-03-31 0.08 -1.14 1.16
2015-12-31 0.05 -2.59 2.61
2015-09-30 0.07 -3.80 3.79
2015-06-30 0.05 -3.49 3.45
2015-03-31 0.03 -3.55 3.47
2014-12-31 0.16 -2.14 2.12
2014-09-30 0.15 -0.85 0.81
2014-06-30 0.15 -1.35 1.54
2014-03-31 0.15 -1.24 1.43
2013-12-31 0.00 -1.13 1.22
2013-09-30 0.00 -0.85 0.94
2013-06-30 0.00 -0.32 0.15
2013-03-31 -0.27 0.10
2012-12-31 -0.28 0.11
2012-09-30 -0.75 0.36
2012-06-30 -0.90 0.52

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if United Health Products has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.
  • It is difficult to establish if United Health Products has efficiently used its assets last year compared to the US Medical Equipment industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if United Health Products improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to its liabilities exceeding its assets.
X
Past performance checks
We assess United Health Products's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Medical Equipment industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
United Health Products has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

UEEC Health

 How is United Health Products's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up United Health Products's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • United Health Products's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • United Health Products has no long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of United Health Products's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • United Health Products has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from United Health Products Company Filings, last reported 1 month ago.

OTCPK:UEEC Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-03-31 -0.54 0.13 0.01
2018-12-31 -0.35 0.01 0.03
2018-09-30 -0.21 0.17 0.13
2018-06-30 0.18 0.19 0.33
2018-03-31 -0.10 0.20 0.16
2017-12-31 -0.26 0.45 0.19
2017-09-30 -0.77 0.46 0.06
2017-06-30 -0.81 0.45 0.00
2017-03-31 -0.70 0.41 0.02
2016-12-31 -0.75 0.33 0.03
2016-09-30 -0.88 0.34
2016-06-30 -0.84 0.32 0.00
2016-03-31 -0.78 0.30 0.01
2015-12-31 -0.80 0.29 0.00
2015-09-30 -0.47 0.38 0.00
2015-06-30 -0.66 0.33 0.00
2015-03-31 -0.94 0.30 0.05
2014-12-31 -1.61 0.71 0.01
2014-09-30 -1.52 1.07 0.00
2014-06-30 -1.43 0.97 0.00
2014-03-31 -1.22 0.84 0.01
2013-12-31 -1.12 0.76 0.00
2013-09-30 -0.97 0.49 0.00
2013-06-30 -1.50 0.48 0.00
2013-03-31 -1.75 0.59
2012-12-31 -1.69 0.45 0.00
2012-09-30 -1.63 0.55 0.00
2012-06-30 -1.57 0.54 0.00
  • United Health Products has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.
  • Irrelevant to check if United Health Products's debt level has increased considering it has negative shareholder equity.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • United Health Products has less than a year of cash runway based on current free cash flow.
  • United Health Products has less than a year of cash runway if free cash flow continues to grow at historical rates of 35.1% each year.
X
Financial health checks
We assess United Health Products's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. United Health Products has a total score of 1/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

UEEC Dividends

 What is United Health Products's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from United Health Products dividends.
If you bought $2,000 of United Health Products shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate United Health Products's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate United Health Products's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
OTCPK:UEEC Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
United States of America Medical Equipment Industry Average Dividend Yield Market Cap Weighted Average of 24 Stocks 1.3%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 2007 Stocks 2.5%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.5%
United States of America Top 25% Dividend Yield 75th Percentile 3.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as United Health Products has not reported any payouts.
  • Unable to verify if United Health Products's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of United Health Products's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as United Health Products has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess United Health Products's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can United Health Products afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. United Health Products has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

UEEC Management

 What is the CEO of United Health Products's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Doug Beplate
COMPENSATION $180,000
AGE 63
TENURE AS CEO 4.5 years
CEO Bio

Mr. Douglas K. Beplate, also known as Doug, had been the Chief Operating Officer of United Health Products, Inc. from November, 2013 until July, 2018 and has been its Chief Executive Officer and President since November 10, 2014 and he became a Director and Chairman of the Board of the Company in 2015. Mr. Beplate has been the Chief Operating Officer of Epic Wound Care, Inc. since June 7, 2012. He has been working on the development and marketing of the Hemostyp gauze since 2010, where his responsibilities include daily operations and oversight of sales, marketing, product development and intellectual property. He was Founder of NMI Health Inc. and served as its President from July 2000 to February 16, 2007 and also served as its Principal Executive Officer. Mr. Beplate was responsible for product design, research and development, patent work and production. From 1996 to 2007, Mr. Beplate was Founder and President of Emergency Filtration Products, Inc. (EFP) where his responsibilities included product design, research and development, patent work and production. Prior to his position with Emergency Filtration, he served as a consultant to various medical products firms from 1993 to 1996 where he was involved in research and development and product design. Mr. Beplate is also an experienced entrepreneur and business Manager. He founded Kinder tot, Inc. and served for it from 1990 to 1993. He was also the Founder of Applied Nanoscience, Inc. and served as its Director. He served as a Director of Nano Mask, Inc. from July 2000 to February 16, 2007. During his time at EFP, Mr. Beplate was awarded a grant through California State University San Bernardino for development of nanotechnology for the U.S. government and military sector.

CEO Compensation
  • Doug's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Doug's remuneration is lower than average for companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the United Health Products management team in years:

4.5
Average Tenure
63
Average Age
  • The tenure for the United Health Products management team is about average.
Management Team

Doug Beplate

TITLE
President & CEO
COMPENSATION
$180K
AGE
63
TENURE
4.5 yrs

Nate Knight

TITLE
CFO, Secretary
AGE
69
TENURE
6.3 yrs

Louis Schiliro

TITLE
Chief Operating Officer
AGE
47
TENURE
0.8 yrs
Board of Directors Tenure

Average tenure and age of the United Health Products board of directors in years:

1.2
Average Tenure
68
Average Age
  • The average tenure for the United Health Products board of directors is less than 3 years, this suggests a new board.
Board of Directors

Nate Knight

TITLE
CFO, Secretary
AGE
69
TENURE
6.4 yrs

David Ramey

TITLE
Member of Medical Advisory Board
TENURE
1.2 yrs

Robert Denser

TITLE
Director
AGE
47
TENURE
4.5 yrs

Zachariah Zachariah

TITLE
Member of Medical Advisory Board
AGE
68
TENURE
1.2 yrs

Richard Massoth

TITLE
Member of Medical Advisory Board
TENURE
1.2 yrs

Joseph Chalil

TITLE
Member of Medical Advisory Board
TENURE
1.2 yrs

Michael Jessen

TITLE
Member of Medical Advisory Board
TENURE
1.2 yrs

Gerard Abate

TITLE
Member of Medical Advisory Board
TENURE
1.2 yrs

Lawrence Wolff

TITLE
Member of Medical Advisory Board

Clay Robinson

TITLE
Member of Medical Advisory Board
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
X
Management checks
We assess United Health Products's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. United Health Products has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

UEEC News

Simply Wall St News

UEEC Company Info

Description

United Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. The company offers HemoStyp hemostatic gauze products to absorb exudate/drainage from superficial wounds, as well as helps in controlling bleeding. It also provides gauze products for oral surgery; Trauma Gauze products for battlefield trauma, as well as adhesive bandages for use by consumers on cuts and abrasions; and island dressings to support intravenous procedures. In addition, it provides its products with customized private labeling. The company serves veterinarian, dental, medical, military, and sports markets. It also offers its products to the consumer market through Walmart.com. The company was formerly known as United EcoEnergy Corp. and changed its name to United Health Products, Inc. in September 2010. United Health Products, Inc. was founded in 1997 and is based in Henderson, Nevada.

Details
Name: United Health Products, Inc.
UEEC
Exchange: OTCPK
Founded: 1997
$157,714,544
176,217,368
Website: http://www.unitedhealthproductsinc.com
Address: United Health Products, Inc.
10624 South Eastern Avenue,
Suite A209,
Henderson,
Nevada, 89052,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
OTCPK UEEC Common Shares Pink Sheets LLC US USD 14. Feb 2007
Number of employees
Current staff
Staff numbers
4
United Health Products employees.
Industry
Health Care Supplies
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/05/26 00:04
End of day share price update: 2019/05/24 00:00
Last earnings filing: 2019/05/15
Last earnings reported: 2019/03/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.